top of page
At the forefront of innovation in tissue matching ultrasound couplants
SonoClear at a glance
COMPANY
COMPANY
SonoClear in numbers
2
Publications
5
Patents
59
Treated patients
FUNDRAISING
Our investors and
financial support
MISSION
Are you interested in joining our mission?
2009 – 2012
Preclinical testing.
2013 – 2016
Phase 1 clinical investigation. 15 Glioblastoma patients (St Olav’s Hospital)
2017 – 2022
Early prototype testing, Verification and Validation studies, Regulatory strategy, Initiation of phase 1 of pivotal multi-centre clinical investigation in high- and low-grade Glioma patients. (Germany, Italy and Slovakia). COVID-19
2023
Appointment of Peter Balmforth as CEO, Completion of phase 1 of pivotal multi-centre clinical investigation.
bottom of page